This page is part of the HL7 FHIR Implementation Guide: minimal Common Oncology Data Elements (mCODE) Release 1 - US Realm | STU1 (v1.16.0: STU 2 Ballot 1) based on FHIR R4. The current version which supercedes this version is 2.0.0. For a full list of available versions, see the Directory of published versions
@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix sct: <http://snomed.info/id/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
# - resource -------------------------------------------------------------------
a fhir:MedicationAdministration;
fhir:nodeRole fhir:treeRoot;
fhir:Resource.id [ fhir:value "cancer-related-medication-administration-doxorubicin-jenny-m"];
fhir:Resource.meta [
fhir:Meta.profile [
fhir:value "http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-cancer-related-medication-administration";
fhir:index 0;
fhir:link <http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-cancer-related-medication-administration> ]
];
fhir:DomainResource.text [
fhir:Narrative.status [ fhir:value "generated" ];
fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><p><b>status</b>: completed</p><p><b>category</b>: <span title=\"Codes: {http://terminology.hl7.org/CodeSystem/medicationrequest-category outpatient}\">Outpatient</span></p><p><b>medication</b>: <span title=\"Codes: {http://www.nlm.nih.gov/research/umls/rxnorm 1790099}\">doxorubicin hydrochloride 20 MG per 10 ML Injection</span></p><p><b>subject</b>: <a href=\"Patient-cancer-patient-jenny-m.html\">Generated Summary: Medical Record Number: MRN1234 (USUAL); Jenny M ; gender: female; birthDate: 1965-01-01</a></p><p><b>effective</b>: 2018-04-22</p><h3>Performers</h3><table class=\"grid\"><tr><td>-</td><td><b>Actor</b></td></tr><tr><td>*</td><td><a href=\"Practitioner-us-core-practitioner-nancy-oncology-nurse.html\">Generated Summary: id: 55667788; Nancy Nurse ; gender: female</a></td></tr></table><p><b>reasonReference</b>: <a href=\"Condition-primary-cancer-condition-jenny-m.html\">Generated Summary: <span title=\"Codes: {http://terminology.hl7.org/CodeSystem/condition-clinical remission}\">Remission</span>; <span title=\"Codes: {http://terminology.hl7.org/CodeSystem/condition-ver-status confirmed}\">Confirmed</span>; <span title=\"Codes: {http://terminology.hl7.org/CodeSystem/condition-category problem-list-item}\">Problem List Item</span>; <span title=\"Codes: {http://snomed.info/sct 353431000119107}\">Primary malignant neoplasm of female left breast (disorder)</span>; onset: 2018-03-16</a></p><p><b>request</b>: <a href=\"MedicationRequest-cancer-related-medication-request-doxorubicin-jenny-m.html\">Generated Summary: status: active; intent: order; <span title=\"Codes: {http://terminology.hl7.org/CodeSystem/medicationrequest-category outpatient}\">Outpatient</span>; <span title=\"Codes: {http://www.nlm.nih.gov/research/umls/rxnorm 3639}\">DOXOrubicin</span>; authoredOn: 2018-04-12</a></p><p><b>note</b>: doxorubicin (60 mg/m² IV), 105.96 mg in 50 ml 0.9% normal saline administered by continuous infusion. Patient tolerated infusion without side effects. (By Practitioner/us-core-practitioner-nancy-oncology-nurse @2018-04-22)</p><h3>Dosages</h3><table class=\"grid\"><tr><td>-</td><td><b>Route</b></td><td><b>Dose</b></td></tr><tr><td>*</td><td><span title=\"Codes: {http://snomed.info/sct 47625008}\">Intravenous route (qualifier value)</span></td><td>105.96 mg</td></tr></table></div>"
];
fhir:MedicationAdministration.status [ fhir:value "completed"];
fhir:MedicationAdministration.category [
fhir:CodeableConcept.coding [
fhir:index 0;
fhir:Coding.system [ fhir:value "http://terminology.hl7.org/CodeSystem/medicationrequest-category" ];
fhir:Coding.code [ fhir:value "outpatient" ] ]
];
fhir:MedicationAdministration.medicationCodeableConcept [
fhir:CodeableConcept.coding [
fhir:index 0;
fhir:Coding.system [ fhir:value "http://www.nlm.nih.gov/research/umls/rxnorm" ];
fhir:Coding.code [ fhir:value "1790099" ];
fhir:Coding.display [ fhir:value "doxorubicin hydrochloride 20 MG per 10 ML Injection" ] ]
];
fhir:MedicationAdministration.subject [
fhir:Reference.reference [ fhir:value "Patient/cancer-patient-jenny-m" ]
];
fhir:MedicationAdministration.effectiveDateTime [ fhir:value "2018-04-22"^^xsd:date];
fhir:MedicationAdministration.performer [
fhir:index 0;
fhir:MedicationAdministration.performer.actor [
fhir:Reference.reference [ fhir:value "Practitioner/us-core-practitioner-nancy-oncology-nurse" ] ]
];
fhir:MedicationAdministration.reasonReference [
fhir:index 0;
fhir:Reference.reference [ fhir:value "Condition/primary-cancer-condition-jenny-m" ]
];
fhir:MedicationAdministration.request [
fhir:Reference.reference [ fhir:value "MedicationRequest/cancer-related-medication-request-doxorubicin-jenny-m" ]
];
fhir:MedicationAdministration.note [
fhir:index 0;
fhir:Annotation.authorReference [
fhir:Reference.reference [ fhir:value "Practitioner/us-core-practitioner-nancy-oncology-nurse" ] ];
fhir:Annotation.time [ fhir:value "2018-04-22"^^xsd:date ];
fhir:Annotation.text [ fhir:value "doxorubicin (60 mg/m² IV), 105.96 mg in 50 ml 0.9% normal saline administered by continuous infusion. Patient tolerated infusion without side effects." ]
];
fhir:MedicationAdministration.dosage [
fhir:MedicationAdministration.dosage.route [
fhir:CodeableConcept.coding [
fhir:index 0;
a sct:47625008;
fhir:Coding.system [ fhir:value "http://snomed.info/sct" ];
fhir:Coding.code [ fhir:value "47625008" ];
fhir:Coding.display [ fhir:value "Intravenous route (qualifier value)" ] ] ];
fhir:MedicationAdministration.dosage.dose [
fhir:Quantity.value [ fhir:value "105.96"^^xsd:decimal ];
fhir:Quantity.unit [ fhir:value "mg" ];
fhir:Quantity.system [ fhir:value "http://unitsofmeasure.org" ];
fhir:Quantity.code [ fhir:value "mg" ] ]
].
# - ontology header ------------------------------------------------------------
a owl:Ontology;
owl:imports fhir:fhir.ttl.